IL6 and breast cancer: The levels of IL-6 and TNF-α in the MC group were significantly higher than those in the BC group (p < 0.001), and the levels of IL-6 and TNF-α were reduced after ZBVO and mosapride treatment, and the levels of IL-6 and TNF-α in ZBVO-HD group were more similar to those in the BC group.